Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?

BACKGROUND: To identify dosimetric parameters associated with acute hematologic toxicity (HT) in rectal cancer patients undergoing concurrent chemotherapy and intensity-modulated pelvic radiotherapy. METHODS: Ninety-three rectal cancer patients receiving concurrent capecitabine and pelvic intensity-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Juefeng, Liu, Kaitai, Li, Kaixuan, Li, Guichao, Zhang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554292/
https://www.ncbi.nlm.nih.gov/pubmed/26238572
http://dx.doi.org/10.1186/s13014-015-0454-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554292/
https://www.ncbi.nlm.nih.gov/pubmed/26238572
http://dx.doi.org/10.1186/s13014-015-0454-0

Ejemplares similares